378 related articles for article (PubMed ID: 20960525)
21. Long-term survivor of brain metastases from malignant melanoma.
Mahmood H; Faheem M; Asghar AH; Irfan J
J Coll Physicians Surg Pak; 2010 Dec; 20(12):832-4. PubMed ID: 21205554
[TBL] [Abstract][Full Text] [Related]
22. Skin metastases of malignant melanoma: a clinical and prognostic survey.
Savoia P; Fava P; Nardò T; Osella-Abate S; Quaglino P; Bernengo MG
Melanoma Res; 2009 Oct; 19(5):321-6. PubMed ID: 19641475
[TBL] [Abstract][Full Text] [Related]
23. Stage-IV melanoma and pulmonary metastases: factors predictive of survival.
Neuman HB; Patel A; Hanlon C; Wolchok JD; Houghton AN; Coit DG
Ann Surg Oncol; 2007 Oct; 14(10):2847-53. PubMed ID: 17680317
[TBL] [Abstract][Full Text] [Related]
24. [Cerebral metastasis of melanoma: study of 48 patients].
Muñoz JE; Viñolas N; Castro J; Graus F; Conde C; Castel T; Biete A; Tolosa E; Estapé J
Med Clin (Barc); 1993 Nov; 101(18):684-7. PubMed ID: 8114524
[TBL] [Abstract][Full Text] [Related]
25. Gamma knife radiosurgery for malignant melanoma brain metastases.
Seung SK; Sneed PK; McDermott MW; Shu HK; Leong SP; Chang S; Petti PL; Smith V; Verhey LJ; Wara WM; Phillips TL; Larson DA
Cancer J Sci Am; 1998; 4(2):103-9. PubMed ID: 9532412
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of beta1 integrin expression in metastatic melanoma.
Vihinen P; Nikkola J; Vlaykova T; Hahka-Kemppinen M; Talve L; Heino J; Pyrhönen S
Melanoma Res; 2000 Jun; 10(3):243-51. PubMed ID: 10890378
[TBL] [Abstract][Full Text] [Related]
27. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study.
Buchsbaum JC; Suh JH; Lee SY; Chidel MA; Greskovich JF; Barnett GH
Cancer; 2002 Apr; 94(8):2265-72. PubMed ID: 12001126
[TBL] [Abstract][Full Text] [Related]
28. The prognostic impact of the extent of lymph node dissection in patients with stage III melanoma.
Galliot-Repkat C; Cailliod R; Trost O; Danino A; Collet E; Lambert D; Vabres P; Dalac S
Eur J Surg Oncol; 2006 Sep; 32(7):790-4. PubMed ID: 16822643
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors for survival in patients with brain metastases from renal cell carcinoma.
Culine S; Bekradda M; Kramar A; Rey A; Escudier B; Droz JP
Cancer; 1998 Dec; 83(12):2548-53. PubMed ID: 9874462
[TBL] [Abstract][Full Text] [Related]
30. Clinical presentation, natural history and prognostic factors in advanced malignant melanoma.
Amer MH; Al-Sarraf M; Vaitkevicius VK
Surg Gynecol Obstet; 1979 Nov; 149(5):687-92. PubMed ID: 505243
[TBL] [Abstract][Full Text] [Related]
31. Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade.
Milsch L; Gesierich A; Kreft S; Livingstone E; Zimmer L; Goebeler M; Schadendorf D; Schilling B
Eur J Cancer; 2018 Aug; 99():58-65. PubMed ID: 29906735
[TBL] [Abstract][Full Text] [Related]
32. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma.
Hughes TM; A'Hern RP; Thomas JM
Br J Surg; 2000 Jul; 87(7):892-901. PubMed ID: 10931025
[TBL] [Abstract][Full Text] [Related]
33. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
[TBL] [Abstract][Full Text] [Related]
34. Survival with regional and distant metastases from cutaneous malignant melanoma.
Roses DF; Karp NS; Oratz R; Dubin N; Harris MN; Speyer J; Boyd A; Golomb FM; Ransohoff J; Dugan M
Surg Gynecol Obstet; 1991 Apr; 172(4):262-8. PubMed ID: 2006449
[TBL] [Abstract][Full Text] [Related]
35. [Current treatment of melanoma metastases of the brain].
Fedorcsák I; Sipos L
Magy Onkol; 2003; 47(1):109-12. PubMed ID: 12704463
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases.
DiLuna ML; King JT; Knisely JP; Chiang VL
Cancer; 2007 Jan; 109(1):135-45. PubMed ID: 17133440
[TBL] [Abstract][Full Text] [Related]
37. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients.
Gutzmer R; Al Ghazal M; Geerlings H; Kapp A
Br J Dermatol; 2005 Dec; 153(6):1137-41. PubMed ID: 16307648
[TBL] [Abstract][Full Text] [Related]
38. Cerebral metastases of cutaneous melanoma.
Gupta G; Robertson AG; MacKie RM
Br J Cancer; 1997; 76(2):256-9. PubMed ID: 9231928
[TBL] [Abstract][Full Text] [Related]
39. Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features.
Raizer JJ; Hwu WJ; Panageas KS; Wilton A; Baldwin DE; Bailey E; von Althann C; Lamb LA; Alvarado G; Bilsky MH; Gutin PH
Neuro Oncol; 2008 Apr; 10(2):199-207. PubMed ID: 18287337
[TBL] [Abstract][Full Text] [Related]
40. Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival.
Zakrzewski J; Geraghty LN; Rose AE; Christos PJ; Mazumdar M; Polsky D; Shapiro R; Berman R; Darvishian F; Hernando E; Pavlick A; Osman I
Cancer; 2011 Apr; 117(8):1711-20. PubMed ID: 21472718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
